(Q38056012)

27 August 2017

Trimming the fat: obesity and hematopoietic cell transplantation (English)

1 reference

27 August 2017

0 references

4

E A Stadtmauer

1 reference

27 August 2017

B M Weiss

1

1 reference

27 August 2017

D T Vogl

series ordinal

2

1 reference

27 August 2017

N A Berger

series ordinal

3

1 reference

27 August 2017

H M Lazarus

series ordinal

5

1 reference

27 August 2017

language of work or name

English

0 references

publication date

29 October 2012

1 reference

Bone Marrow Transplantation

27 August 2017

1 reference

27 August 2017

48

1 reference

27 August 2017

9

1 reference

27 August 2017

1152-1160

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2012.201

27 August 2017

0 references

cites work

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Obesity and severe obesity forecasts through 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Annual Deaths Attributable to Obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Body mass index, physical activity, and risk of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Obesity and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Overweight and obesity: prevalence, consequences, and causes of a growing public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Relation between sleep duration and BMI varies by age and sex in youth age 8-19

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Body fat distribution, adipocyte size, and metabolic characteristics of nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Adipocytes impair leukemia treatment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Whole-body adipose tissue analysis: comparison of MRI, CT and dual energy X-ray absorptiometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Quantification of human body fat tissue percentage by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Energy balance, host-related factors, and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Obesity and cancer risk: the role of the insulin-IGF axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Adiponectin, the missing link in insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Leptin signaling in breast cancer: An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

A pathobiological role of the insulin receptor in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

The insulin-like growth factor system in regulation of normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Aberrant expressions of leptin and adiponectin receptor isoforms in chronic myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Targeting the PI3K signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

The major inflammatory mediator interleukin-6 and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Interleukin-6 induces hepcidin expression through STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Mechanisms of cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Patients with morbid obesity don't get life-saving bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Variability in determination of body weight used for dosing busulphan and cyclophosphamide in adult patients: results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Obesity and outcomes in premenopausal and postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Weight, weight gain, and survival after breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Obesity and therapy-related toxicity in patients treated for small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Cancer and obesity: effect of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Effects of endurance training on the physical performance of patients with hematological malignancies during chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Effects of an exercise program on muscle performance in patients undergoing allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

The haematopoietic effects of growth hormone and insulin-like growth factor-I

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Subcutaneous adipocyte size and body fat distribution

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Reconstitution of lethally irradiated mice by cells isolated from adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Linking the inflammasome to obesity-related disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: gender and site differences

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Anthropometric measurements in the elderly: age and gender differences

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Expression of the leptin receptor in human leukaemic blast cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Obesity and autologous stem cell transplantation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Doxorubicin clearance in the obese

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Body mass and mortality after breast cancer diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Undertreatment of obese women receiving breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Prevalence and significance of vitamin D deficiency in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Physical Activity and Recovery from Hematological Malignancy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

A randomized trial of the effect of a walking regimen on the functional status of 100 adult allogeneic donor hematopoietic cell transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Total energy expenditure and body composition changes following peripheral blood stem cell transplantation and participation in an exercise programme

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.201

7 January 2021

Identifiers

DOI

10.1038/BMT.2012.201

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference